Categories Consumer, Earnings

General Motors (GM) beats Q4 earnings estimates; misses on revenue

General Motors Company (NYSE: GM) reported better-than-expected earnings for the fourth quarter of 2019 while revenues missed the mark. Shares gained 2.5% in premarket hours on Wednesday.

Total revenue of $30.8 billion fell 19.7% year-over-year, missing estimates of $31.04 billion.

On a GAAP basis, the company reported a net loss of $232 million, or $0.16 per share, compared to a net income of $2 billion, or $1.40 per share, in the prior-year period. Adjusted EPS fell 96% to $0.05, but beat forecasts of $0.01.

General Motors reports Q4 2019 earnings results

GM announced a $2.2 billion investment in its Detroit-Hamtramck plant to produce a full line-up of all-electric trucks and SUVs, including the GMC Hummer EV. The production of electric pickup trucks will begin in the fall of 2021.

During the quarter, GM lost four weeks of vehicle production due to the work stoppage, reducing wholesales by 191,000 units year-over-year. The company’s market share in the US decreased year-over-year mainly due to the US labor disruption and discontinuation of some passenger cars.

Also read: Spotify Q4 2019 Earnings Report

GM also saw its market share in China decline due to segment shifts, lower demand for outgoing models and the slower rate of adoption of new fuel efficient technology.

Looking into 2020, GM is expected to benefit from new vehicle launches, ongoing cost savings and lean US inventory. The company will launch the Chevrolet Tahoe and Suburban, the GMC Yukon and Yukon XL and the Cadillac Escalade this year.

For fiscal year 2020, GM expects both GAAP and adjusted EPS to come in the range of $5.75-6.25.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top